Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
590
-
Total 13F shares, excl. options
-
26.3M
-
Shares change
-
+1.01M
-
Total reported value, excl. options
-
$8.27B
-
Value change
-
+$320M
-
Put/Call ratio
-
1.81
-
Number of buys
-
294
-
Number of sells
-
-276
-
Price
-
$313.86
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q2 2025
656 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q2 2025.
Medpace Holdings, Inc. - Common Stock (MEDP) has 590 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.3M shares
of 30.9M outstanding shares and own 85.31% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (2.46M shares), VANGUARD GROUP INC (2.39M shares), WASATCH ADVISORS LP (946K shares), Mawer Investment Management Ltd. (817K shares), STATE STREET CORP (707K shares), RENAISSANCE TECHNOLOGIES LLC (678K shares), GEODE CAPITAL MANAGEMENT, LLC (638K shares), AQR CAPITAL MANAGEMENT LLC (621K shares), BAILLIE GIFFORD & CO (522K shares), and BESSEMER GROUP INC (508K shares).
This table shows the top 590 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.